Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

BiVictrix Therapeutics (BVX)

Price 13.00p on 19-07-2024 at 16:30:03
Change 0.00p 0%
Buy 14.00p
Sell 12.00p
Buy / Sell BVX Shares
Last Trade: -
Day's Volume: 0
Last Close: 13.00p
Open: 13.00p
ISIN: GB00BNXH3K91
Day's Range 13.00p - 13.00p
52wk Range: 9.00p - 15.30p
Market Capitalisation: £11m
VWAP: 0.00p
Shares in Issue: 83m

Recent Trades History BiVictrix Therapeutics (BVX)

Buy/Sell Volume Trade Prc Trade Type Trade Time

Share Price History for BiVictrix Therapeutics

Time period:
to
Date Open High Low Close Volume

Share News for BiVictrix Therapeutics

EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss

13th Jun 2024 19:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: CT UK High Income tops benchmark, ups dividend

31st May 2024 19:00

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Bivictrix granted FDA orphan drug status for rare cancer treatment

17th Apr 2024 14:23

(Alliance News) - Bivictrix Therapeutics PLC on Wednesday said its BVX001 drug has been granted special status by the US Food and Drug Administration. Read More

IN BRIEF: Bivictrix selects final sequences for lead tumour programme

30th Nov 2023 12:08

Bivictrix Therapeutics PLC - Macclesfield, England-based biotechnology company focused on cancer therapies - Says final sequences have been selected for its second programme BVX002, an antibody drug conjugate or ADC targeting solid tumour indications. Emerging data identifies high-grade serous ovarian cancer as one of the lead indications. Company says it is on track to identify the development lead in 2024. Says findings represent "significant unmet need and commercial potential for BVX002". Read More

TRADING UPDATES: BiVictriX patent boost; 4Global deal extended

15th Nov 2023 13:05

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value8,155.72
Change-49.17

Login to your account

Forgot Password?

Not Registered